SANTA ANA, Calif.--(BUSINESS WIRE)--MP Biomedicals CEO Milan Panic and RUSNANO CEO Anatoly Chubais have signed an agreement of cooperation. The parties have agreed to cooperate in the areas of nanotechnology research and development, in creation and modernization of an R&D base, and in providing due conditions for production of innovative pharmaceuticals, including personal pharmacogenetic treatments.